3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
21
Phase 1
12
Phase EARLY_PHASE1
7
Phase 2
5
Phase 1/2
3
Phase 4
2
Phase 2/3
2
Phase 3
1
Status
Completed
30
Recruiting
10
Unknown
9
Terminated
6
Active not recruiting
5
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Breast Neoplasms
41
Carcinoma, Non-Small-Cell Lung
28
Colorectal Neoplasms
16
Neoplasms
13
Nasopharyngeal Carcinoma
11
Lung Neoplasms
10
Leukemia, Myeloid, Acute
10
Carcinoma, Hepatocellular
10
Stomach Neoplasms
9
Prostatic Neoplasms
9
Ovarian Neoplasms
8
Multiple Myeloma
8
Squamous Cell Carcinoma of Head and Neck
7
Small Cell Lung Carcinoma
7
Rectal Neoplasms
7
Esophageal Neoplasms
7
Triple Negative Breast Neoplasms
6
Pancreatic Neoplasms
6
Non-Muscle Invasive Bladder Neoplasms
6
Uterine Cervical Neoplasms
5
Recurrence
5
Neoplasm Metastasis
5
Glioblastoma
5
Colonic Neoplasms
5
Brain Neoplasms
5
Adenocarcinoma
5
Urinary Bladder Neoplasms
4
Polycystic Ovary Syndrome
4
Lymphoma, Follicular
4
Fallopian Tube Neoplasms
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Not yet recruiting
×
Hematologic Neoplasms
×
Clear all
NCT06278896
2024-02-26
END
Brigham and Women's Hospital
Phase 3
Not yet recruiting
260 enrolled